Canonical and non-canonical effects of the NLRP3 inflammasome in kidney inflammation and fibrosis.
about
Inflammasomes in the Pathophysiology of Kidney DiseasesSecondary amyloidosis in autoinflammatory diseases and the role of inflammation in renal damagePathophysiological role of different tubular epithelial cell death modes in acute kidney injuryNephropathy in dietary hyperoxaluria: A potentially preventable acute or chronic kidney diseaseInnate And Adaptive Immunity are Progressively Activated in Parallel with Renal Injury in the 5/6 Renal Ablation Model.The emerging role of the inflammasome in kidney diseasesRegulated cell death in AKI.Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathyActivation of the Nlrp3 inflammasome by mitochondrial reactive oxygen species: a novel mechanism of albumin-induced tubulointerstitial inflammation.Role of NLRP3 Inflammasomes for Rhabdomyolysis-induced Acute Kidney InjuryAn update on the role of the inflammasomes in the pathogenesis of kidney diseases.Involvement of endoplasmic reticulum stress in angiotensin II-induced NLRP3 inflammasome activation in human renal proximal tubular cells in vitroDefects in MAP1S-mediated autophagy turnover of fibronectin cause renal fibrosis.Anti-inflammatory interventions-what has worked, not worked, and what may work in the future.Diabetes and Kidney Disease: Role of Oxidative Stress.Nlrp3 prevents early renal interstitial edema and vascular permeability in unilateral ureteral obstruction.Icariin ameliorates IgA nephropathy by inhibition of nuclear factor kappa b/Nlrp3 pathway.NLRP3 inflammasome: Pathogenic role and potential therapeutic target for IgA nephropathy.Beyond tissue injury-damage-associated molecular patterns, toll-like receptors, and inflammasomes also drive regeneration and fibrosis.Hyperuricemia-induced NLRP3 activation of macrophages contributes to the progression of diabetic nephropathy.Asbestos-Induced Mesothelial to Fibroblastic Transition Is Modulated by the Inflammasome.NLRP3 inflammasome activation contributes to aldosterone-induced podocyte injury.Inflammasomes in the urinary tract: a disease-based review.Oxalate, inflammasome, and progression of kidney diseasePostischemic microvasculopathy and endothelial progenitor cell-based therapy in ischemic AKI: update and perspectives.Of Inflammasomes and Alarmins: IL-1β and IL-1α in Kidney Disease.Inflammasome Activation in Chronic Glomerular Diseases.Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets.Crystal nephropathies: mechanisms of crystal-induced kidney injury.Efficacy and Pharmacology of the NLRP3 Inflammasome Inhibitor CP-456,773 (CRID3) in Murine Models of Dermal and Pulmonary Inflammation.Pioglitazone ameliorates glomerular NLRP3 inflammasome activation in apolipoprotein E knockout mice with diabetes mellitus.Curcumin Ameliorates Diabetic Nephropathy by Suppressing NLRP3 Inflammasome Signaling.A molecular morphometric approach to diabetic kidney disease can link structure to function and outcome.A tissue-specific role for Nlrp3 in tubular epithelial repair after renal ischemia/reperfusion.The NLPR3 inflammasome and obesity-related kidney disease.Inhibition of NLRP3 inflammasome: a new protective mechanism of cinnamaldehyde in endotoxin poisoning of mice.Resveratrol-loaded nanoparticles conjugated with kidney injury molecule-1 as a drug delivery system for potential use in chronic kidney disease.Tim-3 exacerbates kidney ischemia reperfusion injury through TLR4/NF-κB signaling pathway and an NLRC4 inflammasome activation.Hydroxychloroquine attenuates renal ischemia/reperfusion injury by inhibiting cathepsin mediated NLRP3 inflammasome activation.Egr-1 deficiency protects from renal inflammation and fibrosis.
P2860
Q26740458-E6F71EF5-1BEB-40D1-88FB-10A90111FF33Q26770744-02EC1E62-52BA-476F-A71E-D0BA87690F59Q26785893-6E84E990-ED8A-4C27-B086-1B53320BECBFQ26865804-4F7A59BD-F2FD-405F-94D1-C05FA8417512Q33784394-5FFB00B0-3F1A-4EDF-8B22-D527871FA37EQ34307043-65583399-DBD0-47E1-8018-CB86A6EA125FQ34568839-A2DA8E13-A256-403A-8690-A64D939528B0Q34836376-CF980E57-559D-4D06-8618-E7724AA29BDCQ35551778-F1D18A8E-DDB2-4F4C-932B-63331DC51A2DQ35686207-A2B7C80A-8489-4974-AE47-DAEBE5DA704EQ35692937-F50F41D5-3EA4-4A1B-A835-43079176CE44Q36743285-F097269D-DDA6-402E-A8AA-73F7663570C3Q37062491-9C0E7A41-0FBA-4248-90CF-4A5E78D3CC57Q37336472-C78F019D-375A-4321-86F1-B27E22AD54DEQ37349206-79163501-2C8D-4D0C-B36C-3E3B252D2C76Q37484299-9C1B7321-3D0E-4D22-A846-EC0F3D5D96FAQ37572909-D0181009-4809-40F8-9463-7B75A61B310CQ37602078-757C03C5-E87C-4542-82EA-3BE284C44A99Q38206875-AA6C6F65-DC4B-4633-A2B3-D36698C70AD2Q38428834-284130F8-B816-464A-9A79-AB7BA6B3BCE6Q38722819-6F15775E-F0D4-4069-A643-E6563F46A381Q38722963-9FFA9C7C-2BFF-414C-A397-C72D89C66F67Q38832656-A9F44D13-E313-45C8-BDEE-8C674BD70517Q38837256-C5AB3777-FD8D-48EF-8166-9FDA5A7224A3Q38838112-87BC6D36-8093-48F6-8D72-2091E38BB957Q38925521-8D46091B-FBA0-4869-BB4B-C5E91125EFE7Q38931056-1810C61D-2EC7-41B4-B5D0-211F61C8747FQ38936622-E1CCBBA0-227E-49EE-94CD-AE037A19345BQ39144172-12949F8D-B05B-4329-BA64-5B386A5F5F69Q39493410-0811142D-FAC2-4851-99A7-98DC42AE81F7Q41017644-6FDBE6A5-F5DB-4018-BE79-CB2B4C396249Q42177918-827DF7FD-2BFB-4221-B886-6E0B7A90F9D0Q45972129-1FF181C3-CBA0-4D2B-88A1-883B9502BD4BQ47096387-980DC179-27B8-4ADF-8DB0-B159C34B3AC8Q47130640-539BB1DE-8693-4ED8-9309-89077730D663Q48004912-1D6B1137-9C45-4CEF-9A52-6F44A72EA529Q48666820-6EA045F3-B71F-42B0-8D37-615DCBCACC81Q52640402-2409A17A-B034-4189-BE8D-1AD97380C167Q52676433-2B0EF6AA-5310-4103-B6E0-6E52EBD1FEC1Q52881458-CD8F9A04-2A5C-4F7C-9D6D-3B9E766671A8
P2860
Canonical and non-canonical effects of the NLRP3 inflammasome in kidney inflammation and fibrosis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Canonical and non-canonical ef ...... ney inflammation and fibrosis.
@en
type
label
Canonical and non-canonical ef ...... ney inflammation and fibrosis.
@en
prefLabel
Canonical and non-canonical ef ...... ney inflammation and fibrosis.
@en
P2860
P356
P1476
Canonical and non-canonical ef ...... dney inflammation and fibrosis
@en
P2093
Georg Lorenz
Murthy N Darisipudi
P2860
P356
10.1093/NDT/GFT332
P407
P577
2013-09-11T00:00:00Z